Kynam Capital Management, LP - 31 Dec 2025 SCHEDULE 13G Report for CytomX Therapeutics, Inc. Common Stock, $0.00001 par value per share (CTMX)

Filing Manager
Kynam Capital Management, LP
Reporting Manager
Kynam Capital Management, LP
Security
CytomX Therapeutics, Inc. Common Stock, $0.00001 par value per share
Symbol
CTMX
Shares outstanding
169,491,059 shares
Disclosed Ownership
8,966,077 shares
Ownership
5.3%
Form type
SCHEDULE 13G
Filing time
04 Mar 2026, 15:18:13 UTC
Date of event
31 Dec 2025
SEC
View on sec.gov

Sponsored

Quoteable Key Fact

"Kynam Capital Management, LP disclosed 5.3% ownership in CytomX Therapeutics, Inc. Common Stock, $0.00001 par value per share (CTMX) on 31 Dec 2025."

Quick Takeaways

  • Kynam Capital Management, LP filed SCHEDULE 13G for CytomX Therapeutics, Inc. Common Stock, $0.00001 par value per share (CTMX).
  • Disclosed ownership: 5.3%.
  • Date of event: 31 Dec 2025.

What Changed

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 04 Mar 2026, 15:18.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Source Evidence

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (3)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Kynam Capital Management, LP 5.3% 8,966,077 0 8,966,077 Yue Tang Managing Member
Kynam Capital Management GP, LLC 5.3% 8,966,077 0 8,966,077 Yue Tang Managing Member
Yue Tang 5.3% 8,966,077 0 8,966,077 Yue Tang Self

Sponsored